(Q36618245)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26354929%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

title

Kinetics of tumor size and peritumoral brain edema before, during, and after systemic therapy in recurrent WHO grade II or III meningioma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26354929%20AND%20SRC:MED&resulttype=core&format=json

World Health Organization

23 February 2020

main subject

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26354929%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Anna S Berghoff

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26354929%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Matthias Preusser

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26354929%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

5

Roberta Rudà

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26354929%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

14

Riccardo Soffietti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26354929%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

Julia Furtner

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26354929%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Katharina Seystahl

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26354929%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Emilie Le Rhun

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26354929%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Ulrich Roelcke

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26354929%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Susanne Koeppen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26354929%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Christine Marosi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26354929%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Paul Clement

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26354929%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Marina Faedi

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26354929%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Colin Watts

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26354929%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Wolfgang Wick

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26354929%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Michael Weller

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26354929%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

publication date

9 September 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26354929%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26354929%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26354929%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26354929%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

page(s)

401-407

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26354929%20AND%20SRC:MED&resulttype=core&format=json

CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011.

23 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767240

Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767240

Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767240

Atypical and anaplastic meningiomas treated with bevacizumab.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767240

Microvascularization and expression of VEGF and its receptors in recurring meningiomas: pathobiological data in favor of anti-angiogenic therapy approaches.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767240

Phase II study of subcutaneous octreotide in adults with recurrent or progressive meningioma and meningeal hemangiopericytoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767240

Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767240

Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08).

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767240

Salvage chemotherapy with CPT-11 for recurrent meningioma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767240

Temozolomide for treatment-resistant recurrent meningioma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767240

A phase II trial of PTK787/ZK 222584 in recurrent or progressive radiation and surgery refractory meningiomas.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767240

Expression of vascular endothelial growth factor (VEGF) and its receptors VEGFR1 and VEGFR2 in primary and recurrent WHO grade III meningiomas

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767240

Peritumoral brain edema in angiomatous supratentorial meningiomas: an investigation of the vascular endothelial growth factor A pathway

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767240

Role of VEGF and matrix metalloproteinase-9 in peritumoral brain edema associated with supratentorial benign meningiomas

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767240

The Austrian Brain Tumour Registry: a cooperative way to establish a population-based brain tumour registry

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767240

Interferon-alpha for recurrent World Health Organization grade 1 intracranial meningiomas

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767240

Improving lesion-symptom mapping

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767240

Long-term administration of mifepristone (RU486): clinical tolerance during extended treatment of meningioma.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767240

New editorial team for neuro-oncology

20 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOV183

Recurrent meningioma: salvage therapy with long-acting somatostatin analogue

21 January 2018

1 reference

12 December 2020

Radiographic regression of vestibular schwannomas induced by bevacizumab treatment: sustain under continuous drug application and rebound after drug discontinuation

1 reference

12 December 2020

Bevacizumab-induced regression of anaplastic meningioma

1 reference

12 December 2020

Vascular endothelial growth factor: the major factor for tumor neovascularization and edema formation in meningioma patients

1 reference

12 December 2020

Hydroxyurea for recurrent surgery and radiation refractory high-grade meningioma

1 reference

12 December 2020

Lack of efficacy of megestrol acetate in the treatment of unresectable meningioma

1 reference

12 December 2020

Identifiers

DOI

10.1093/NEUONC/NOV183

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26354929%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26354929%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

PubMed publication ID

26354929

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26354929%20AND%20SRC:MED&resulttype=core&format=json